Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,32119,340 of 20,252 grants

Completed NON SBIR/STTR CONTRACTS
SITE LICENSE TO AJCC CANCER STAGING MANUAL, 8TH EDITION
NATIONAL CANCER INSTITUTE American College of Surgeons United States 2021 – 2022

In order to continue the collection and reporting of cancer staging data by the SEER registries, the NCI/DCCPS SEER program requires access to the most current cancer staging data.

$1.45M
USD
Completed OTHER RESEARCH-RELATED
COG NCTN Network Group Operations Center
NATIONAL CANCER INSTITUTE Public Health Institute United States 2021 – 2025

PROJECT SUMMARY Since the introduction of chemotherapy for the treatment of childhood leukemia more than 60-years ago, the prognosis of childhood cancer has improved dramatically.T...

$612.6K
USD
Completed NON-SBIR/STTR RPGS
Dose finding designs for late-onset toxicities
NATIONAL CANCER INSTITUTE University of Virginia United States 2021 – 2022

Project Summary / Abstract: The current landscape of oncology drug development is posing a challenge to widely-accepted methods used in dose-finding clinical trials. One of the big...

$806K
USD
Completed NON-SBIR/STTR RPGS
TRPV1 nociceptors in oral carcinogenesis and pain
NATIONAL CANCER INSTITUTE New York University United States 2021 – 2026

Project Summary Oral cancer pain is more severe than all other cancers. Patients with metastatic oral cancer experience the greatest pain. Oral cancers activate neurons and produce...

$6.27M
USD
Completed NON-SBIR/STTR RPGS
Immunogenomic determinants of response and resistance to neoadjuvant anti-PD-1 in resectable NSCLC
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Summary More than 1.8 million people worldwide are diagnosed with non-small cell lung cancer (NSCLC) every year. Of these patients, 20% present with stage I or II disease. For thes...

$3.75M
USD
Completed NON-SBIR/STTR RPGS
Administrative Supplement for VICKtOrY Early Clinical Trials Consortium
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2022

ABSTRACT: This application is being submitted to request additional funds for three Affiliated Organizations (AOs) to an NCI Experimental Therapeutics-Clinical Trials Network (ETCT...

$1M
USD
Completed NON-SBIR/STTR RPGS
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2026

PROJECT SUMMARY Activating KRAS mutations, altered metabolism, and an immunosuppressive tumor microenvironment are all hallmarks of pancreatic ductal adenocarcinoma (PDAC). The rec...

$6.07M
USD
Completed NON-SBIR/STTR RPGS
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

Clinical radiation therapy is a noninvasive means to mitigate cancer progression, which is prescribed for more than 50% of prostate cancer patients. Development of radiation techno...

$6.48M
USD
Completed OTHER RESEARCH-RELATED
COG NCTN Network Group Operations Center
NATIONAL CANCER INSTITUTE Public Health Institute United States 2021 – 2022

PROJECT SUMMARY Since the introduction of chemotherapy for the treatment of childhood leukemia more than 60-years ago, the prognosis of childhood cancer has improved dramatically.T...

$135.25M
USD
Completed OTHER RESEARCH-RELATED
COG SDMC - Administrative Core
NATIONAL CANCER INSTITUTE Public Health Institute United States 2021 – 2022

PROJECT SUMMARY This is the Administrative Core to support the overall application for the Children's Oncology Group Statistics and Data Management Center.

Completed NON-SBIR/STTR RPGS
Novel multipronged Immunovirotherapy Approach for GBM Treatment
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

Project Summary Glioblastoma (GBM) prognosis remains dismal with a median survival of 16-18 months despite the use of multimodality treatment. Immunotherapy attempts have been unsu...

$3.52M
USD
Completed NON-SBIR/STTR RPGS
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer Therapy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2026

Cancers that depend on the spatial location of the disease affect all ethnicities and age groups, accounting for significant mortality and therapy-related side effects. In one inst...

$5.39M
USD
Completed OTHER RESEARCH-RELATED
PRECISE - a PErsonalized Risk Score for gastrIc CancEr
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

The National Cancer Institute has called for eliminating disparities in cancer morbidity and mortality through the use of Data Science. Gastric cancer remains one of the most unequ...

$1.88M
USD
Completed OTHER RESEARCH-RELATED
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2025

PROJECT SUMMARYTuberous Sclerosis Complex (TSC) is a genetic syndrome that predisposes patients to tumor formation and is often diagnosed during infancy. Brain lesions, including s...

$872K
USD
Completed OTHER RESEARCH-RELATED
A Multilevel intervention to address health disparities in lung cancer screening
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2023

Abstract Lung cancer is the leading cause of cancer-related mortality in the US, with more than 135,000 deaths expected in 2020. Based on the National Lung Screening Trial, which s...

$1.18M
USD
Completed TRAINING, INDIVIDUAL
Dissecting the Gut Microbiota for Immune Checkpoint Blockade (ICB) - Resisting Microbes and Exploring the Generalizability of Microbiota-ICB Studies
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2025

PROJECT SUMMARY Immune checkpoint blockade (ICB) has yielded durable tumor regression and stabilized disease in 10-30% of patients for a range of solid and hematological malignanci...

$465.9K
USD
Completed NON-SBIR/STTR RPGS
Lung epithelial lineage-specific factors in the control of immune system evasion genes in tumor cells
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2024

ABSTRACT Cancer cells that are capable of escaping host immune system defenses typically adopt more aggressive behaviors. Novel immunotherapies targeting these mechanisms are now s...

$780K
USD
Completed NON-SBIR/STTR RPGS
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

Project Summary Metastatic colorectal cancer (mCRC) is the second leading cause of cancer-related mortality in the United States, and annually accounts for nearly 500,000 deaths wo...

$6.04M
USD
Completed NON-SBIR/STTR RPGS
A transformative drug discovery platform for allosteric kinase inhibitors
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2026

Project Summary The University of Minnesota (UMN) and Photonic Pharma (PP) a Minnesota-based drug discovery start-up, have partnered to optimize, field-test, and deploy at industri...

$5.72M
USD
Completed OTHER RESEARCH-RELATED
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Tobacco is the leading cause of preventable death and disease and is linked to approximately 20 cancers. The rate of decline of tobacco use has been lower...

$1.33M
USD